FDA.report

Application 090289

Type
ANDA
Sponsor
TEVA PHARMS

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001LETROZOLELETROZOLETABLET;ORAL2.5MGNoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
0093-7620LetrozoleLetrozoleTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7620LetrozoleLetrozoleTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7620LetrozoleLetrozoleTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7620LetrozoleLetrozoleTeva Pharmaceuticals USA, Inc.ANDACurrent
42254-243LetrozoleLetrozoleRebel Distributors CorpANDACurrent
42291-374LetrozoleLetrozoleAvKARE, Inc.ANDACurrent
42291-374LetrozoleLetrozoleAvKAREANDACurrent
70518-2020LetrozoleLetrozoleREMEDYREPACK INC.ANDACurrent
71205-587LetrozoleLetrozoleProficient Rx LPANDACurrent